The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

is this combo good?

Jun 22, 2008

hi there can you tell me if this combo is good PREZISTA(DARUNAVIR)+NORVIR?twice daily ?im resistant to sustiva group..

Response from Dr. Young

Thanks for your post.

I'm wondering if you're referring to a first-line treatment.

For those who have acquired NNRTI ("efavirenz group") resistance, using a ritonavir-boosted PI is definitely recommend for part of a treatment regimen (though not to be used alone). Darunavir is a very potent PI that is currently approved (and recommended) for patients with drug resistant virus, but not yet commonly used in first-line regimens. That said, the medication is very well tolerated and is finding some use in these patients.

We'd typically start with more well studied first-line PIs, such as fosamprenavir (Lexiva, Telzir) or atazanavir (Reyataz), in combination with either Truvada or Epzicom-- these offer well tolerated options that are endorsed by current treatment guidelines.

I hope this helps,



  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint